Results 181 to 190 of about 12,153 (191)

Associations between UGT1A1*6 or UGT1A1*6/*28 polymorphisms and irinotecan-induced neutropenia in Asian cancer patients

Cancer Chemotherapy and Pharmacology, 2014
Li-Li Gong, Fei-Fei Han, Lihong Liu
exaly  

UGT1A1 polymorphisms with irinotecan-induced toxicities and treatment outcome in Asians with Lung Cancer: a meta-analysis

Cancer Chemotherapy and Pharmacology, 2017
Minzhang Guo, Jian-Xing He, Qiuhua Deng
exaly  

Limited influence of UGT1A1*28 and no effect of UGT2B7*2 polymorphisms on UGT1A1 or UGT2B7 activities and protein expression in human liver microsomes

British Journal of Clinical Pharmacology, 2007
Theunis Goosen, J Andrew Williams
exaly  

Effects of UGT1A1 genotype on the pharmacokinetics, pharmacodynamics, and toxicities of belinostat administered by 48-hour continuous infusion in patients with cancer

Journal of Clinical Pharmacology, 2016
Susan E Bates, Cody J Peer, Sanjeeve Balasubramaniam   +2 more
exaly  

Correlation between UGT1A1 polymorphisms and raltegravir plasma trough concentrations in Japanese HIV-1-infected patients

Journal of Infection and Chemotherapy, 2015
Dai Watanabe, Tomoko Uehira, Keishiro Yajima   +2 more
exaly  

UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity

Pharmacogenomics Journal, 2002
exaly  

Polymorphisms in the UGT1A1 gene predict adverse effects of irinotecan in the treatment of gynecologic cancer in Japanese patients

Journal of Human Genetics, 2013
Hiroyuki Nomura, Tomoko Akahane, Nobuyuki Susumu   +2 more
exaly  

HAPLOTYPES OF THE UGT1A1 GENE

2002
CHEW ANNE, CHOI JULIE Y, KOSHY BEENA, ROUNDS EILEEN   +3 more
openaire   +1 more source

[Importance and practice of UGT1A1 polymorphisms].

Nihon rinsho. Japanese journal of clinical medicine, 2013
Atsushi, Watanabe, Takashi, Shimada
openaire   +1 more source

[Importance and practice of UGT1A1 polymorphisms].

Nihon rinsho. Japanese journal of clinical medicine, 2012
Shoichi, Hazama, Masaaki, Oka
openaire   +1 more source